TruScient

RSS

Withdrawn

This medicine's authorisation has been withdrawn

dibotermin alfa
MedicineVeterinaryWithdrawn

Spanish is available via eTranslation, the European Commission's machine translation service.

Translate to Spanish | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for TruScient has been withdrawn at the request of the marketing authorisation holder.

български (BG) (218.13 KB - PDF)

Ver

español (ES) (219.39 KB - PDF)

Ver

čeština (CS) (221.21 KB - PDF)

Ver

dansk (DA) (196.28 KB - PDF)

Ver

Deutsch (DE) (219.87 KB - PDF)

Ver

eesti (ET) (220.58 KB - PDF)

Ver

ελληνικά (EL) (223.98 KB - PDF)

Ver

français (FR) (220.78 KB - PDF)

Ver

italiano (IT) (218.46 KB - PDF)

Ver

latviešu (LV) (216.78 KB - PDF)

Ver

lietuvių (LT) (218.76 KB - PDF)

Ver

magyar (HU) (239.21 KB - PDF)

Ver

Malti (MT) (219.92 KB - PDF)

Ver

Nederlands (NL) (195.35 KB - PDF)

Ver

polski (PL) (222.4 KB - PDF)

Ver

português (PT) (196.44 KB - PDF)

Ver

română (RO) (219.8 KB - PDF)

Ver

slovenčina (SK) (242.89 KB - PDF)

Ver

slovenščina (SL) (233.64 KB - PDF)

Ver

suomi (FI) (195.98 KB - PDF)

Ver

svenska (SV) (193.82 KB - PDF)

Ver

Product information

български (BG) (443.35 KB - PDF)

Ver

español (ES) (365.02 KB - PDF)

Ver

čeština (CS) (425.46 KB - PDF)

Ver

dansk (DA) (371.48 KB - PDF)

Ver

Deutsch (DE) (397.22 KB - PDF)

Ver

eesti (ET) (417.19 KB - PDF)

Ver

ελληνικά (EL) (464.42 KB - PDF)

Ver

français (FR) (425.36 KB - PDF)

Ver

italiano (IT) (399.85 KB - PDF)

Ver

latviešu (LV) (426.83 KB - PDF)

Ver

lietuvių (LT) (428.56 KB - PDF)

Ver

magyar (HU) (436.37 KB - PDF)

Ver

Malti (MT) (483.67 KB - PDF)

Ver

Nederlands (NL) (410.73 KB - PDF)

Ver

polski (PL) (443.92 KB - PDF)

Ver

português (PT) (374.05 KB - PDF)

Ver

română (RO) (427.72 KB - PDF)

Ver

slovenčina (SK) (431.78 KB - PDF)

Ver

slovenščina (SL) (430.91 KB - PDF)

Ver

suomi (FI) (391.15 KB - PDF)

Ver

svenska (SV) (396.36 KB - PDF)

Ver

Íslenska (IS) (381.08 KB - PDF)

Ver

norsk (NO) (390.32 KB - PDF)

Ver
Latest procedure affecting product information:IAIN/0005/G
15/01/2015

български (BG) (410.19 KB - PDF)

Ver

español (ES) (394.1 KB - PDF)

Ver

čeština (CS) (404.3 KB - PDF)

Ver

dansk (DA) (393.94 KB - PDF)

Ver

Deutsch (DE) (387.42 KB - PDF)

Ver

eesti (ET) (387.03 KB - PDF)

Ver

ελληνικά (EL) (407.02 KB - PDF)

Ver

français (FR) (386.86 KB - PDF)

Ver

italiano (IT) (259.23 KB - PDF)

Ver

latviešu (LV) (276.1 KB - PDF)

Ver

lietuvių (LT) (267.12 KB - PDF)

Ver

magyar (HU) (272.45 KB - PDF)

Ver

Malti (MT) (275.42 KB - PDF)

Ver

Nederlands (NL) (259.53 KB - PDF)

Ver

polski (PL) (275.32 KB - PDF)

Ver

português (PT) (259.68 KB - PDF)

Ver

română (RO) (271.55 KB - PDF)

Ver

slovenčina (SK) (275.09 KB - PDF)

Ver

slovenščina (SL) (265.89 KB - PDF)

Ver

suomi (FI) (393.53 KB - PDF)

Ver

svenska (SV) (263.95 KB - PDF)

Ver

Íslenska (IS) (259.1 KB - PDF)

Ver

norsk (NO) (263.99 KB - PDF)

Ver

Product details

Name of medicine
TruScient
Active substance
dibotermin alfa
International non-proprietary name (INN) or common name
dibotermin alfa
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QM05BC01

Pharmacotherapeutic group

Bone morphogenetic proteins

Therapeutic indication

Osteoinductive agent for use in the treatment of long-bone fractures as an adjunct to standard surgical care using open fracture reduction in dogs.

Authorisation details

EMA product number
EMEA/V/C/002000
Marketing authorisation holder
Zoetis Belgium SA

Rue Laid Burniat 1
1348 Louvain-la-Neuve
Belgium

Marketing authorisation issued
14/12/2011
Revision
4

Assessment history

This page was last updated on

Share this page